Houston cleantech incubator adds 3 startups in its latest cohort

now accelerating

Halliburton Labs has announced its next set of clean energy tech companies. Photo courtesy of Halliburton

Three climatetech companies will be joining Halliburton Labs, a Houston-based energy transition incubator.

Chemergy, EVA, and Novamera will be joining Halliburton Labs, the company announced last week. The three startups will receive technical support, access to Halliburton's global connections, and more from the program.

“We are excited to help accelerate three innovative companies that emerged from our recent Finalists Pitch Day,” says Dale Winger, managing director of Halliburton Labs, in a news release. “We will work closely with these founders and their teams to achieve strategic, operational, and financial milestones with the most efficient use of their time and capital."

Halliburton Labs launched in the summer of 2020, and now has over a dozen companies working on climatetech solutions in its portfolio. Applications are now open for the next cohort on the Halliburton Labs website and are due by April 22, for the May 20 Finalists Pitch Day.

"In less than two years, we've established productive new relationships with fifteen companies scaling solutions across a breadth of markets to expand our understanding of new value chains,” Winger continues.

Here's a little more about the three new additions to the program.

Chemergy

Miami-based Chemergy has created a patented HyBrTec process is designed to convert wet organic and plastic wastes into green hydrogen, thereby eliminating the liability and consequences of the wastes by converting them into fuel.

“We see a great opportunity to collaborate with Halliburton Labs' industrial experience to ensure our systems can be installed and operated safely in communities to solve waste disposal issues, improve resiliency and sustainability, and produce cleaner fuel locally,” says Melahn Parker, president of Chemergy.

EVA

EVA, a New York headquartered company with a presence on four continents, is increasing scalability for the drone industry with its ground infrastructure and operating system solutions that help customers perform inspections, make deliveries, recharge, and monitor remote operations without local manpower.

“The Halliburton Labs ‘scalerator' model comes at the right time for EVA as we accelerate commercialization," says Olivier Le Lann, founder and CEO. "We're excited about the ways Halliburton's global market and industrial expertise will accelerate our trajectory."

Novamera

Canadian company Novamera has developed proprietary navigation tools and software that enables climate smart, surgical mining and unlocks value in certain mineral deposits found worldwide that are otherwise uneconomic due to their small scale and geometry.

“We are pleased to join Halliburton Labs' accelerator program," says Novamera Co-founder and CEO Dustin Angelo in a news release. "Their engineering expertise and business experience will help us accelerate the development of our technology and scale our business to bring a more sustainable method of mining to the world.”

Ad Placement 300x100

Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Rice University lands $18M to revolutionize lymphatic disease detection

fresh funding

An arm of the U.S. Department of Health and Human Services has awarded $18 million to scientists at Rice University for research that has the potential to revolutionize how lymphatic diseases are detected and help increase survivability.

The lymphatic system is the network of vessels all over the body that help eliminate waste, absorb fat and maintain fluid balance. Diseases in this system are often difficult to detect early due to the small size of the vessels and the invasiveness of biopsy testing. Though survival rates of lymph disease have skyrocketed in the United States over the last five years, it still claims around 200,000 people in the country annually.

Early detection of complex lymphatic anomalies (CLAs) and lymphedema is essential in increasing successful treatment rates. That’s where Rice University’s SynthX Center, directed by Han Xiao and Lei Li, an assistant professor of electrical and computer engineering, comes in.

Aided by researchers from Texas Children’s Hospital, Baylor College of Medicine, the University of Texas at Dallas and the University of Texas Southwestern Medical Center, the center is pioneering two technologies: the Visual Imaging System for Tracing and Analyzing Lymphatics with Photoacoustics (VISTA-LYMPH) and Digital Plasmonic Nanobubble Detection for Protein (DIAMOND-P).

Simply put, VISTA-LYMPH uses photoacoustic tomography (PAT), a combination of light and sound, to more accurately map the tiny vessels of the lymphatic system. The process is more effective than diagnostic tools that use only light or sound, independent of one another. The research award is through the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics and pHenotyping Technologies (LIGHT) program, part of the U.S. HHS, which saw the potential of VISTA-LYMPH in animal tests that produced finely detailed diagnostic maps.

“Thanks to ARPA-H’s award, we will build the most advanced PAT system to image the body’s lymphatic network with unprecedented resolution and speed, enabling earlier and more accurate diagnosis,” Li said in a news release.

Meanwhile, DIAMOND-P could replace the older, less exact immunoassay. It uses laser-heated vapors of plasmonic nanoparticles to detect viruses without having to separate or amplify, and at room temperature, greatly simplifying the process. This is an important part of greater diagnosis because even with VISTA-LYMPH’s greater imaging accuracy, many lymphatic diseases still do not appear. Detecting biological markers is still necessary.

According to Rice, the efforts will help address lymphatic disorders, including Gorham-Stout disease, kaposiform lymphangiomatosis and generalized lymphatic anomaly. They also could help manage conditions associated with lymphatic dysfunction, including cancer metastasis, cardiovascular disease and neurodegeneration.

“By validating VISTA-LYMPH and DIAMOND-P in both preclinical and clinical settings, the team aims to establish a comprehensive diagnostic pipeline for lymphatic diseases and potentially beyond,” Xiao added in the release.

The ARPA-H award funds the project for up to five years.

Houston doctor wins NIH grant to test virtual reality for ICU delirium

Virtual healing

Think of it like a reverse version of The Matrix. A person wakes up in a hospital bed and gets plugged into a virtual reality game world in order to heal.

While it may sound far-fetched, Dr. Hina Faisal, a Houston Methodist critical care specialist in the Department of Surgery, was recently awarded a $242,000 grant from the National Institute of Health to test the effects of VR games on patients coming out of major surgery in the intensive care unit (ICU).

The five-year study will focus on older patients using mental stimulation techniques to reduce incidences of delirium. The award comes courtesy of the National Institute on Aging K76 Paul B. Beeson Emerging Leaders Career Development Award in Aging.

“As the population of older adults continues to grow, the need for effective, scalable interventions to prevent postoperative complications like delirium is more important than ever,” Faisal said in a news release.

ICU delirium is a serious condition that can lead to major complications and even death. Roughly 87 percent of patients who undergo major surgery involving intubation will experience some form of delirium coming out of anesthesia. Causes can range from infection to drug reactions. While many cases are mild, prolonged ICU delirium may prevent a patient from following medical advice or even cause them to hurt themselves.

Using VR games to treat delirium is a rapidly emerging and exciting branch of medicine. Studies show that VR games can help promote mental activity, memory and cognitive function. However, the full benefits are currently unknown as studies have been hampered by small patient populations.

Faisal believes that half of all ICU delirium cases are preventable through VR treatment. Currently, a general lack of knowledge and resources has been holding back the advancement of the treatment.

Hopefully, the work of Faisal in one of the busiest medical cities in the world can alleviate that problem as she spends the next half-decade plugging patients into games to aid in their healing.

New accelerator joins the Ion and more Houston innovation news to know

Trending News

Editor's note: The Houston innovation scene is buzzing with big news this month, from a new accelerator joining the fold at the Ion to pre-IPO funding and national expansion plans. Below are the five most-read InnovationMap stories from Feb. 1-15, 2026:

New accelerator for AI startups to launch at Houston's Ion this spring

The new AI Native Dual-Use Sports, Health & Wellness Accelerator is expected to launch in March. Photo courtesy of the Ion

The Collectiv Foundation and Rice University have established a sports, health and wellness startup accelerator at the Ion District’s Collectiv, a sports-focused venture capital platform. The AI Native Dual-Use Sports, Health & Wellness Accelerator is scheduled to formally launch in March. Continue reading.

10+ can't-miss Houston business and innovation events in February

From recurring monthly favorites to the return of annual celebrations and summits, here's what not to miss in February. Photo courtesy the Ion.

February may be a short month, but its event calendar isn’t. From recurring monthly favorites to the return of annual celebrations and summits, here are the Houston business and innovation events not to miss — and how to register. Continue reading.

View All Listings

INNOVATIONMAP EMAILS ARE AWESOME